On November 8, 2010
What Genzyme’s CEO Doesn’t Know, and Doesn’t Want to Know, About Sanofi’s Hostile Bid
Genzyme CEO Henri Termeer’s refusal to meet With Sanofi CEO Chris Viehbacher suggests he doesn’t have the information he needs to evaluate Sanofi’s $69/share offer.
No tags for this post.
0 Comments